🧠 Sanofi Acquires Vigil Neuroscience to Advance Alzheimer’s Treatment
May 22, 2025 | Health & Pharma News In a major development for neurodegenerative disease research, Sanofi, the French pharmaceutical giant, has announced the acquisition of Vigil Neuroscience, a U.S.-based biotech firm specializing in treatments for rare neuroinflammatory conditions. The…
